Nilsson J - Search Results

1

SUMO pathway inhibition targets an aggressive pancreatic cancer subtype.

Biederstädt A, Hassan Z, Schneeweis C, Schick M, Schneider L, Muckenhuber A, Hong Y, Siegers G, Nilsson L, Wirth M, Dantes Z, Steiger K, Schunck K, Langston S, Lenhof HP, Coluccio A, Orben F, Slawska J, Scherger A, Saur D, Müller S, Rad R, Weichert W, Nilsson J, Reichert M, Schneider G, Keller U. Biederstädt A, et al. Among authors: nilsson j, nilsson l. Gut. 2020 Aug;69(8):1472-1482. doi: 10.1136/gutjnl-2018-317856. Epub 2020 Jan 30. Gut. 2020. PMID: 32001555 Free PMC article.

2

Id2 is dispensable for myc-induced lymphomagenesis.

Nilsson JA, Nilsson LM, Keller U, Yokota Y, Boyd K, Cleveland JL. Nilsson JA, et al. Cancer Res. 2004 Oct 15;64(20):7296-301. doi: 10.1158/0008-5472.CAN-04-2133. Cancer Res. 2004. PMID: 15492249

3

Targeting ornithine decarboxylase in Myc-induced lymphomagenesis prevents tumor formation.

Nilsson JA, Keller UB, Baudino TA, Yang C, Norton S, Old JA, Nilsson LM, Neale G, Kramer DL, Porter CW, Cleveland JL. Nilsson JA, et al. Cancer Cell. 2005 May;7(5):433-44. doi: 10.1016/j.ccr.2005.03.036. Cancer Cell. 2005. PMID: 15894264 Free article.

4

Nfkb 1 is dispensable for Myc-induced lymphomagenesis.

Keller U, Nilsson JA, Maclean KH, Old JB, Cleveland JL. Keller U, et al. Oncogene. 2005 Sep 15;24(41):6231-40. doi: 10.1038/sj.onc.1208779. Oncogene. 2005. PMID: 15940251

5

Ink4c is dispensable for tumor suppression in Myc-induced B-cell lymphomagenesis.

Nilsson LM, Keller UB, Yang C, Nilsson JA, Cleveland JL, Roussel MF. Nilsson LM, et al. Among authors: nilsson ja. Oncogene. 2007 May 3;26(20):2833-9. doi: 10.1038/sj.onc.1210104. Epub 2006 Nov 13. Oncogene. 2007. PMID: 17099725

6

Myc targets Cks1 to provoke the suppression of p27Kip1, proliferation and lymphomagenesis.

Keller UB, Old JB, Dorsey FC, Nilsson JA, Nilsson L, MacLean KH, Chung L, Yang C, Spruck C, Boyd K, Reed SI, Cleveland JL. Keller UB, et al. EMBO J. 2007 May 16;26(10):2562-74. doi: 10.1038/sj.emboj.7601691. Epub 2007 Apr 26. EMBO J. 2007. PMID: 17464290 Free PMC article.

7

Myc sensitizes p53-deficient cancer cells to the DNA-damaging effects of the DNA methyltransferase inhibitor decitabine.

Höglund A, Nilsson LM, Forshell LP, Maclean KH, Nilsson JA. Höglund A, et al. Blood. 2009 Apr 30;113(18):4281-8. doi: 10.1182/blood-2008-10-183475. Epub 2009 Jan 29. Blood. 2009. PMID: 19179467 Free article.

8

Skp2 directs Myc-mediated suppression of p27Kip1 yet has modest effects on Myc-driven lymphomagenesis.

Old JB, Kratzat S, Hoellein A, Graf S, Nilsson JA, Nilsson L, Nakayama KI, Peschel C, Cleveland JL, Keller UB. Old JB, et al. Mol Cancer Res. 2010 Mar;8(3):353-62. doi: 10.1158/1541-7786.MCR-09-0232. Epub 2010 Mar 2. Mol Cancer Res. 2010. PMID: 20197382 Free PMC article.

9

Aurora kinases A and B are up-regulated by Myc and are essential for maintenance of the malignant state.

den Hollander J, Rimpi S, Doherty JR, Rudelius M, Buck A, Hoellein A, Kremer M, Graf N, Scheerer M, Hall MA, Goga A, von Bubnoff N, Duyster J, Peschel C, Cleveland JL, Nilsson JA, Keller U. den Hollander J, et al. Among authors: nilsson ja. Blood. 2010 Sep 2;116(9):1498-505. doi: 10.1182/blood-2009-11-251074. Epub 2010 Jun 2. Blood. 2010. PMID: 20519624 Free PMC article.

10

Myc suppression of Nfkb2 accelerates lymphomagenesis.

Keller U, Huber J, Nilsson JA, Fallahi M, Hall MA, Peschel C, Cleveland JL. Keller U, et al. Among authors: nilsson ja. BMC Cancer. 2010 Jul 2;10:348. doi: 10.1186/1471-2407-10-348. BMC Cancer. 2010. PMID: 20598117 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,284 results

Search Page